Coave Therapeutics

Biotechnology Research • 63b, Avenue Ledru-Rollin, France • 21-50 Employees

Company overview

Headquarters	63b, Avenue Ledru-Rollin, Paris, Île-de-France 75012, FR
Website	coavetx.com
NAICS	541714
Keywords	Gene Therapy, Médecine, Ophtalmologie, Cns Disease, Thérapie Génique, Rare Ocular Disease
Founded	2014
Employees	21-50
Socials

Key Contacts at Coave Therapeutics

Rodolphe Clerval

Chief Executive Officer

Emmanuel Galene

Director Technical Operations

Julien Spatazza

Senior Director, Discovery & Preclinical Research

Brahim Belbellaa

Senior Director Preclinical Ophtalmology

Sandrine Meunier

Director Of Clinical Development At Coave Therapeutics Then Eyedna Therapeutics

Coave Therapeutics Email Formats

Coave Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@coavetx.com), used 54.8% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@coavetx.com	54.8%
{first name}{last name}	johndoe@coavetx.com	32.3%
{first initial}.{last name}	j.doe@coavetx.com	6.5%
{last name}{last name}	doedoe@coavetx.com	6.5%

About Coave Therapeutics

Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.

Coave Therapeutics revenue & valuation

Annual revenue	$3,935,530
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,600,000
Total funding	$32,900,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

Vice President

Employees by Department

Coave Therapeutics has 27 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Coave Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-02-09	4	$32,900,000

Funding Insights

$32,900,000

Total funding amount

$32,900,000

Most recent funding amount

Number of funding rounds

Coave Therapeutics Tech Stack

Discover the technologies and tools that power Coave Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Maps

Maps

MonsterInsights

Analytics

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

Slider Revolution

Photo galleries

wpBakery

Page builders

Frequently asked questions

Coave Therapeutics is located in 63b, Avenue Ledru-Rollin, FR.

Coave Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Coave Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Coave Therapeutics has raised a total of $32,900,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.